home / stock / cmxhf / cmxhf news


CMXHF News and Press, CSL Ltd.

Stock Information

Company Name: CSL Ltd.
Stock Symbol: CMXHF
Market: OTC

Menu

CMXHF CMXHF Quote CMXHF Short CMXHF News CMXHF Articles CMXHF Message Board
Get CMXHF Alerts

News, Short Squeeze, Breakout and More Instantly...

CMXHF - CSL Limited (CSLLY) Q2 2026 Earnings Call Transcript

2026-02-10 22:24:20 ET CSL Limited (CSLLY) Q2 2026 Earnings Call February 10, 2026 6:00 PM EST Company Participants Mark Dehring Gordon Naylor Ken Lim - Chief Financial Officer Andy Schmeltz - Chief Commercial Officer Dave Ross - Senior VP & GM of S...

CMXHF - CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of Interim CEO Transcript

2026-02-10 06:14:33 ET CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of Interim CEO February 10, 2026 1:00 AM EST... Read the full article on Seeking Alpha For further details see: CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of I...

CMXHF - CSL Limited: Upside Potential Is Strong From These Levels But I Remain Cautious

2026-01-28 06:01:24 ET CSL Limited ( CMXHF ) ( CSLLY ) (CSL.AX) recently crossed my watchlist because the share is trading at a P/E ratio lower than at any point in the last 10 years, while revenue and profits are growing.... Read the full article on Seeking Alpha For fu...

CMXHF - Outperform Recommendation Issued On CMXHF By RBC Capital

2026-01-19 06:15:04 ET RBC Capital analyst issues OUTPERFORM recommendation for CMXHF on January 19, 2026 11:54AM ET. CMXHF was trading at $121.49 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations

CMXHF - Flu medication is in short supply in part of U.S. as cases soar

2026-01-08 07:20:06 ET More on Gilead Sciences, CVS , etc. Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Call - Slideshow CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript ...

CMXHF - Inside the ASX Biotech Boom: What's Fuelling the Next Wave

2026-01-01 15:55:00 ET Australia’s healthcare and biotechnology sector has matured into one of the most promising and strategically important segments of the ASX. Fortunes can shift on a single clinical trial result. A company with no revenue today could be a global contender tomor...

CMXHF - Washington state resident dies from bird flu strain never before detected in humans

2025-11-22 08:33:19 ET More on GSK, Sanofi, etc. GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 Transcript CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript GSK plc (GSK) Q3 2025 Earnings Call Transcript AnaptysBio dr...

CMXHF - Australian biotech CSL announces $1.5B investment in the U.S.

2025-11-18 10:59:06 ET More on CSL CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript CSL Limited (CSLLY) Shareholder/Analyst Call Transcript CSL Limited (CSLLY) Shareholder/Analyst Call - Slideshow Seeking Alpha’s Quant Rating on CSL...

CMXHF - CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript

2025-11-04 23:46:25 ET CSL Limited (CSLLY) Analyst/Investor Day November 4, 2025 6:00 PM EST Company Participants Fiona Mead - Company Secretary & Head of Corporate Governance Paul McKenzie - MD, CEO & Executive Director Dave Ross - Senior VP & GM of Se...

CMXHF - CSL Limited (CSLLY) Shareholder/Analyst Call Transcript

2025-10-28 04:57:39 ET CSL Limited (CSLLY) Shareholder/Analyst Call October 27, 2025 7:01 PM EDT Company Participants Fiona Mead - Company Secretary & Head of Corporate Governance Brian McNamee Paul McKenzie - MD, CEO & Executive Director Brian Daniel...

Next 10